ATE160774T1 - Antipsychotische benzimidazolderivate - Google Patents

Antipsychotische benzimidazolderivate

Info

Publication number
ATE160774T1
ATE160774T1 AT94910462T AT94910462T ATE160774T1 AT E160774 T1 ATE160774 T1 AT E160774T1 AT 94910462 T AT94910462 T AT 94910462T AT 94910462 T AT94910462 T AT 94910462T AT E160774 T1 ATE160774 T1 AT E160774T1
Authority
AT
Austria
Prior art keywords
pct
benzimidazole derivatives
sec
dopamine
substituted
Prior art date
Application number
AT94910462T
Other languages
English (en)
Inventor
Janusz Jozef Kulagowski
Paul David Leeson
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Application granted granted Critical
Publication of ATE160774T1 publication Critical patent/ATE160774T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/14—Radicals substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT94910462T 1993-03-30 1994-03-23 Antipsychotische benzimidazolderivate ATE160774T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939306578A GB9306578D0 (en) 1993-03-30 1993-03-30 Therapeutic agents

Publications (1)

Publication Number Publication Date
ATE160774T1 true ATE160774T1 (de) 1997-12-15

Family

ID=10732977

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94910462T ATE160774T1 (de) 1993-03-30 1994-03-23 Antipsychotische benzimidazolderivate

Country Status (10)

Country Link
US (1) US5792768A (de)
EP (1) EP0691960B1 (de)
JP (1) JPH08508289A (de)
AT (1) ATE160774T1 (de)
AU (1) AU679049B2 (de)
CA (1) CA2159220A1 (de)
DE (1) DE69407176T2 (de)
ES (1) ES2109682T3 (de)
GB (1) GB9306578D0 (de)
WO (1) WO1994022839A1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5633377A (en) * 1990-12-28 1997-05-27 Neurogen Corporation 4-piperidino- and piperazinomethyl-2-cyclohexyl imidazole derivatives; dopamine receptor subtype specific ligands
GB9305644D0 (en) * 1993-03-18 1993-05-05 Merck Sharp & Dohme Therapeutic agents
EP0793653A1 (de) * 1994-11-23 1997-09-10 Neurogen Corporation Einige 4-aminomethyl-2-substituierte imidazolderivate und 2-aminomethyl - 4 - substituierte imidazolderivate; neue klassen von spezifischen liganden des dopaminrezeptorsubtyps
US5773616A (en) * 1995-02-15 1998-06-30 Neurogen Corporation Certain bridged 4-phenyl-2-aminomethylimidazoles; new dopamine receptor subtype specific ligands
WO1996025411A1 (en) * 1995-02-15 1996-08-22 Neurogen Corporation Certain bridged 4-phenyl-2-aminomethylimidazoles; new dopamine receptor subtype specific ligands
US5912246A (en) * 1995-02-15 1999-06-15 Pharmacia & Upjohn Company Imidazo 1,2-a!pyridines for the treatment of CNS and cardiac diseases
US5948912A (en) * 1995-02-15 1999-09-07 Neurogen Corporation Certain bridged 4-phenyl-2-aminomethylimidazoles; new dopamine receptor subtype specific ligands
US6187774B1 (en) * 1996-03-04 2001-02-13 Yoshitomi Pharmaceutical Industries, Ltd. Fused heterocyclic compounds and pharmaceutical applications thereof
DE19637237A1 (de) 1996-09-13 1998-03-19 Merck Patent Gmbh Piperazin-Derivate
HUP0000189A3 (en) 1996-11-15 2002-01-28 Darwin Discovery Ltd Milton Ro Bicyclic aryl carboxamides pharmaceutical compositions containing them and their therapeutic use
US6359882B1 (en) 1997-04-01 2002-03-19 Yipes Communications, Inc. Method and apparatus for transmitting data
US6013654A (en) * 1997-08-14 2000-01-11 Pharmacia & Upjohn Company Imidazo[1,2-A]pyridines for the treatment of CNS and cardiac diseases
US6166205A (en) * 1998-09-02 2000-12-26 Neurogen Corporation 2-Aryl-4-(1-[4-heteroaryl]piperazin-1-yl)methylimidazoles: dopamine . D.sub4 receptor subtype ligands
CN1325397A (zh) * 1998-09-30 2001-12-05 纽罗根公司 2-哌嗪烷基氨基苯并吡咯衍生物∶多巴胺受体亚型特异配体
US6284759B1 (en) 1998-09-30 2001-09-04 Neurogen Corporation 2-piperazinoalkylaminobenzo-azole derivatives: dopamine receptor subtype specific ligands
US6107313A (en) * 1998-10-02 2000-08-22 Combichem, Inc. Dopamine receptor antagonists
DE60009154D1 (de) * 1999-12-30 2004-04-22 Lundbeck & Co As H Phenylpiperazinyl-derivate
IL153884A0 (en) * 2000-07-20 2003-07-31 Neurogen Corp Capsaicin receptor ligands
CZ2003952A3 (cs) * 2000-10-31 2003-11-12 Basf Drucksysteme Gmbh Použití hyperrozvětvených polyurethanů
US7022728B2 (en) * 2001-03-09 2006-04-04 Abbott Laboratories Benzimidazoles that are useful in treating male sexual dysfunction
US20020169166A1 (en) * 2001-03-09 2002-11-14 Cowart Marlon D. Benzimidazoles that are useful in treating sexual dysfunction
KR100863147B1 (ko) * 2001-03-09 2008-10-13 아보트 러보러터리즈 벤즈이미다졸 및 이를 포함하는 성 기능장애 치료용 약제학적 조성물
US6960589B2 (en) * 2001-03-09 2005-11-01 Abbott Laboratories Benzimidazoles that are useful in treating sexual dysfunction
WO2003060475A2 (en) * 2002-01-10 2003-07-24 Neurogen Corporation Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1h-benzoimidazole analogues
AU2003212882A1 (en) 2002-02-01 2003-09-02 Euro-Celtique S.A. 2 - piperazine - pyridines useful for treating pain
US7057042B2 (en) 2002-05-29 2006-06-06 Abbott Laboratories Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction
WO2003101994A1 (en) * 2002-05-29 2003-12-11 Abbott Laboratories Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction
DE60318875T2 (de) * 2002-06-28 2009-01-15 Euro-Celtique S.A. Therapeutische piperazin-derivate für die behandlung von schmerzen
US7262194B2 (en) * 2002-07-26 2007-08-28 Euro-Celtique S.A. Therapeutic agents useful for treating pain
US20040127504A1 (en) * 2002-09-06 2004-07-01 Cowart Marlon D. Benzimidazoles that are useful in treating sexual dysfunction
US7157462B2 (en) 2002-09-24 2007-01-02 Euro-Celtique S.A. Therapeutic agents useful for treating pain
NZ555491A (en) * 2005-01-03 2010-01-29 Univ Siena Aryl piperazine derivatives for the treatment of neuropsychiatric disorders
US7544685B2 (en) 2005-08-17 2009-06-09 H. Lundbeck A/S 2,3-dihydroindole compounds
US7946206B2 (en) * 2007-11-21 2011-05-24 Rocksmart, Llc Quick-release system
US10913736B2 (en) * 2014-08-22 2021-02-09 University Of Washington Specific inhibitors of methionyl-tRNA synthetase
WO2017207340A1 (de) 2016-05-31 2017-12-07 Bayer Pharma Aktiengesellschaft Neue substituierte benzimidazole, verfahren zu ihrer herstellung, pharmazeutische präparate die diese enthalten, sowie deren verwendung zur herstellung von arzneimitteln

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3362956A (en) * 1965-08-19 1968-01-09 Sterling Drug Inc 1-[(heterocyclyl)-lower-alkyl]-4-substituted-piperazines
DK93087A (da) * 1986-02-27 1987-08-28 Duphar Int Res Hidtil ukendte aryl substituerede (n-piperidinyl)methyl- og (n-piperazinyl)methylazoler med antipsykotiske egenskaber
CA2022451C (en) * 1989-08-03 2001-01-23 Albert Anthony Carr Anti-psychotic piperidynl benzimidazole compounds
JPH03102485U (de) * 1990-02-08 1991-10-24
HUT71799A (en) * 1993-03-01 1996-02-28 Merck Sharp & Dohme Pyrrolo-pyridine derivatives, pharmaceutical compositions containing the same, process for producing them

Also Published As

Publication number Publication date
JPH08508289A (ja) 1996-09-03
EP0691960B1 (de) 1997-12-03
CA2159220A1 (en) 1994-10-13
ES2109682T3 (es) 1998-01-16
WO1994022839A1 (en) 1994-10-13
DE69407176D1 (de) 1998-01-15
AU6286994A (en) 1994-10-24
DE69407176T2 (de) 1998-07-02
US5792768A (en) 1998-08-11
AU679049B2 (en) 1997-06-19
GB9306578D0 (en) 1993-05-26
EP0691960A1 (de) 1996-01-17

Similar Documents

Publication Publication Date Title
DE69407176D1 (de) Antipsychotische benzimidazolderivate
ATE160779T1 (de) Antipsychotische indazolderivate
NO953406L (no) Pyrrolo-pyridinderivater
AR016453A1 (es) Pirazolopirimidinas y perazolotriazinas, un procedimiento para su preparacion, medicamentos y el uso de las mismas para la elaboracion de los medicamentos
ES2134929T3 (es) Derivados de pirrolo-piridina como ligandos para receptores de dopamina.
DE69833451D1 (de) Behandlung der schizophrenie mit ampakinen und neuroleptika
MXPA03004243A (es) Derivados de tetrahidrobenzazepina utiles como moduladores de receptores de dopamina d3 (agentes antipsicoticos).
BR9711444A (pt) Derivados de adenosina substituìdos por heterocìclico n6.
ES2178011T3 (es) Derivados de piperazina con una selectividad para el receptor d-4.
ATE401307T1 (de) N-arylsulfonyl-2-substituierte indole mit affinität zum serotonin rezeptor, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
ES2188242T3 (es) Derivados de quinolina.
ATE331707T1 (de) 4 piperazinylindolderivate mit affinität zum 5- ht6-rezeptor
ES2060020T3 (es) Derivados de pirrolidina.
UY24543A1 (es) Sal mesilato trihidrato de 5-(2-(4-(1,2-benzoisotiazol- 3-il)-1-piperazinil)etil)-6-cloro-1,3-dihidro-2h-indol-2-ona
EE03487B1 (et) 5-fenüül-3-(piperidin-4-üül)-1,3,4-oksadiasol-2(3H)-ooni derivaadid kasutamiseks 5-HT4 - või H3- retseptorite ligandidena
MXPA04005847A (es) Compuestos derivados de 4-sulfuro/sulfoxido/sulfonil-1h-pirazolilo, para uso en enfermedades asociadas con el receptor 5-ht2c.
ATE167681T1 (de) Thiazolidinederivate ihre herstellung und sie enthaltende medikamente
DE69930308D1 (de) Selektive 5-ht 6-rezeptor-liganden
WO1994020459A3 (en) Pyrrolo-pyridine derivatives as dopamine receptor ligands
AR029288A1 (es) Derivados de 1-sulfonil-pirrolidina
KR900000092A (ko) 신경 장애의 치료에 있어서 유리딘의 약리학적 용도
ES2159749T3 (es) Derivados de bencilamino-2-metil-propanamidas 2-(4-sustituidas).
SE8801275D0 (sv) New uses of dopamine agonists
NO943133D0 (no) Benzodiazepinderivater egnet til bruk som CCK-reseptorantagonister
EE04905B1 (et) Pridasino[4,5-b]indool-1-atseetamiidi derivaatide kasutamine ravimite valmistamiseks perifeersete bensodiasepiiniretseptorite dsfunktsioneerimisegaseotud haiguste raviks

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties